血尿酸水平对老年充血性心力衰竭患者院内死亡的影响及降尿酸疗效
CSTR:
作者:
作者单位:

(西安交通大学第二附属医院心血管内科,西安710000)

作者简介:

通讯作者:

中图分类号:

基金项目:

陕西省卫生健康科研基金(2022A008);西安交通大学第二附属医院基金护技项目(YJ(HJ)201808)


Impact of serum uric acid level on in-hospital death in elderly patients with congestive heart failure and efficacy of uric acid-lowering therapy
Author:
Affiliation:

(Department of Cardiology, Second Affiliated Hospital of Xi′ an Jiaotong University, Xi′an 710000, China)

Fund Project:

This work was supported by Project of Health Research Fund of Shaanxi Province(2022AOO8) and Fund Nursing Technology Project of the Second Affiliated Hospital of Xi'anJiaotongUniversity(YJ(HJ)2O1808).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 研究老年充血性心力衰竭(CHF)合并高尿酸血症(HUA)患者临床特点,分析降尿酸治疗在改善HUA患者预后中的价值。方法 将2020年7月至2023年5月西安交通大学第二附属医院收治的316例老年CHF患者作为研究对象。根据其入院时血尿酸(SUA)水平,将其分为HUA组及尿酸正常(NHUA)组。比较两组患者临床资料,分析老年CHF合并HUA患者临床特点,统计患者院内死亡情况。采用Cox风险比例回归模型分析影响老年CHF患者院内死亡的相关因素。随机将HUA组患者分为HUA-试验组与HUA-对照组,其中试验组在常规服药基础上加用降尿酸药物别嘌醇。随访1年,对比两组干预效果。采用SPSS 27.0软件进行数据分析。根据数据类型,组间比较分别采用t检验及χ2检验。结果 316例CHF患者中有180例(56.96%)确诊为HUA。HUA组患者SUA、血浆N末端脑钠肽前体(NT-proBNP)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、白细胞计数(WBC)水平以及纽约心脏病协会(NHYA)心功能分级Ⅲ~Ⅳ级者占比高于NHUC组,左心室射血分数(LVEF)水平低于NUHA组,差异均有统计学意义(P<0.05)。316例老年CHF患者院内死亡共23例(7.28%),多因素Cox风险比例回归分析提示,年龄≥80岁(HR=1.399, 95%CI 1.093~1.791)、NT-proBNT水平(HR=1.067, 95%CI 1.022~1.114)、入院24h内利尿剂使用剂量(HR=1.123, 95%CI 1.040~1.212)是患者院内死亡的危险因素,入院时SBP水平(HR=0.911, 95%CI 0.846~0.982)是其保护因素(P<0.05)。随访1年发现,HUA-试验组患者经治疗后,血肌酐、SUA、NT-proBNP、IL-6、TNF-α、WBC、左心室舒张末期内径水平均低于对照组,LVEF水平高于对照组,差异均有统计学意义(P<0.05);HUA-试验组复合终点事件发生率为39.02%(32/82),低于HUA-对照组的59.76%(49/82),差异有统计学意义(χ2=7.050,P=0.008)。结论 入院时SUA水平与老年CHF患者院内死亡无关,但降尿酸治疗可减少患者出院后1年复合终点事件发生率。

    Abstract:

    Objective To investigate the clinical characteristics of elderly patients with congestive heart failure (CHF) complicated with hyperuricemia (HUA) and to analyze the value of uric acid-lowering therapy in improving the prognosis of HUA patients. Methods A total of 316 elderly CHF patients admitted to the Second Affiliated Hospital of Xi′an Jiaotong University from July 2020 to May 2023 were enrolled as the study subjects. According to the serum uric acid (SUA) levels at admission, they were divided into HUA group and non-HVA (NHUA) group. The clinical data were compared between two groups, and the clinical characteristics of elderly CHF patients with HUA were analyzed. The in-hospital mortality was recorded. The factors affecting the in-hospital mortality in elderly CHF patients were analyzed by the Cox proportional hazards regression model. The patients in the HUA group were randomized into HUA-trial group and HUA-control group. The trial group received uric acid-lowering allopurinol in addition to routine medication. After one year of follow-up, the intervention effects were compared. SPSS 27.0 was used for statistical analysis. Data comparison between two groups was performed using t test or χ2test depending on data type. Results Among the 316 CHF patients, 180 (56.96%) were diagnosed with HUA . The HUA group had higher levels of SUA, plasma N-terminal pro-brain natriuretic peptide (NT-proBNP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), white blood cell count (WBC), and proportion of patients with New York Heart Association (NYHA) functional class Ⅲ-Ⅳ than the NHUC group, but lower left ventricular ejection fraction (LVEF), with statistically significant differences (P<0.05). Among 316 elderly CHF patients, 23 (7.28%) died in hospital. Multivariate Cox proportional hazards regression analysis indicated that age ≥ 80 years (HR=1.399, 95%CI 1.093-1.791), NT-proBNT level (HR=1.067, 95%CI 1.022-1.114), and diuretic dose within 24 h of admission (HR=1.123, 95%CI 1.040-1.212) were risk factor for in-hospital death, and systolic blood pressure (SBP) at admission (HR=0.911, 95%CI 0.846-0.982) was a protective factor (P<0.05). After one year of follow-up, levels of serum creatinine, SUA, NT-proBNP, IL-6, TNF-α, WBC, and left ventricular end-diastolic diameter in the HUA-trial group were lower than those in the HUA-control group, while the LVEF was higher than that in the HUA-control group, with statistically significant differences (P<0.05). The incidence of composite endpoint events after one year of follow-up was 39.02% (32/82) in the HUA-experimental group, lower than 59.76% (49/82) in the HUA-control group (χ2=7.050; P=0.008). Conclusion The SUA level at admission is not associated with in-hospital mortality in elderly CHF patients, but uric acid-lowering therapy can reduce the incidence of composite endpoint events one year after discharge.

    参考文献
    相似文献
    引证文献
引用本文

凌丹,刘丹,文红,张艳,周甜,赵珊,王蓉.血尿酸水平对老年充血性心力衰竭患者院内死亡的影响及降尿酸疗效[J].中华老年多器官疾病杂志,2025,24(12):900-905
DOI:10.11915/j. issn.1671-5403.2025.12.191

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-12-27
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-12-16
  • 出版日期:
文章二维码